Cargando…

Extensive intracranial arterial stenoses in conjunction with the use of tyrosine kinase inhibitor Nilotinib

New‐generation tyrosine kinase inhibitors (TKI) are promising agents for the treatment of chronic myeloid leukemia (CML), but the linkage to vascular diseases warrants a special attention from treating physicians, as it may carry major morbidity and mortality.

Detalles Bibliográficos
Autores principales:	Alshiekh‐Nasany, Ruham, Zidan, Awss, Martinez, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134215/ https://www.ncbi.nlm.nih.gov/pubmed/27980759 http://dx.doi.org/10.1002/ccr3.729

Ejemplares similares

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

Magnetic Resonance Imaging-Negative Varicella Zoster Virus Plexopathy in a Young Patient: A Case Report
por: Gül, Sedat, et al.
Publicado: (2023)

Cloning, Sequencing, and the Expression of the Elusive Sarcomeric TPM4α Isoform in Humans
por: Dube, Dipak K., et al.
Publicado: (2016)

Rosai–Dorfman–Destombes disease of the nervous system: a systematic literature review
por: Nasany, Ruham Alshiekh, et al.
Publicado: (2022)

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis
por: Paramarta, Jacqueline E., et al.
Publicado: (2016)

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
por: Carracedo, Miguel, et al.
Publicado: (2020)

Lichen planopilaris-like eruption during treatment with tyrosine kinase inhibitor nilotinib
por: Leitão, Juliana Ribeiro, et al.
Publicado: (2016)

Expression of various sarcomeric tropomyosin isoforms in equine striated muscles
por: Dube, Syamalima, et al.
Publicado: (2017)

Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib
por: Kim, T-M, et al.
Publicado: (2011)

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
por: Ananthula, Hari Krishna, et al.
Publicado: (2018)

Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy
por: Hussain, Tariq, et al.
Publicado: (2019)

Intra-arterial Melphalan for Neurologic Non-Langerhans Cell Histiocytosis
por: Francis, Jasmine H., et al.
Publicado: (2021)

Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells
por: Sako, Hiroyuki, et al.
Publicado: (2014)

The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis
por: Carracedo, Miguel, et al.
Publicado: (2022)

Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery
por: Kim, In Kyoung, et al.
Publicado: (2013)

The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?
por: Omarjee, Loukman, et al.
Publicado: (2017)

Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib
por: Häselbarth, Lukas, et al.
Publicado: (2023)

Association between Leukoaraiosis and Symptomatic Intracranial Large Artery Stenoses and Occlusions: the Chinese Intracranial Atherosclerosis (CICAS) Study
por: Duan, Wanying, et al.
Publicado: (2018)

Intracerebral Hemorrhage with Multiple Intracranial Arterial Stenoses in a Synthetic Cannabinoid “Spice” User
por: Aydin, Seckin, et al.
Publicado: (2018)

Usefulness of Stent Implantation for Treatment of Intracranial Atherosclerotic Stenoses
por: Kim, Kuk Seon, et al.
Publicado: (2012)

A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson’s disease
por: Tanabe, Akie, et al.
Publicado: (2014)

The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
por: Silveira, Elaine, et al.
Publicado: (2018)

Dose optimization strategy of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib for chronic myeloid leukemia: From clinical trials to real-life settings
por: Cheng, Fang, et al.
Publicado: (2023)

Transhepatic approach for rehabilitation of stenosed pulmonary arteries
por: Ebeid, Makram R
Publicado: (2010)

Hemodynamics in Coronary Arterial Tree of Serial Stenoses
por: Chen, Xi, et al.
Publicado: (2016)

Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience
por: Ribeiro, Beatriz Felicio, et al.
Publicado: (2015)

Intracranial Atherosclerotic Stenoses: Pathophysiology, Epidemiology, Risk Factors and Current Therapy Options
por: Krasteva, Marina Petrova, et al.
Publicado: (2020)

Endovascular treatment of idiopathic intracranial hypertension caused by multiple venous sinus stenoses
por: Morisaki, Yudai, et al.
Publicado: (2019)

Stenosing Tendovaginitis
Publicado: (1932)

Simulations of Magnetohemodynamics in Stenosed Arteries in Diabetic or Anemic Models
por: Alshare, Aiman, et al.
Publicado: (2016)

Numerical Investigation of Angulation Effects in Stenosed Renal Arteries
por: Mortazavinia, Z, et al.
Publicado: (2014)

Moyamoya Disease with Peripheral Pulmonary Artery Stenoses and Coronary Artery Fistulae
por: Reardon, Lindsay, et al.
Publicado: (2009)

Vertebral Artery Stenoses Contribute to the Development of Diffuse Plaques in the Basilar Artery
por: Feng, Yundi, et al.
Publicado: (2020)

Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals
por: Ghosh, Arabinda, et al.
Publicado: (2022)

Extensive pulmonary venous stenoses as a complication of radiofrequency catheter ablation for atrial fibrillation
por: Cotella, Juan I., et al.
Publicado: (2022)

Endovascular treatment of patients with high-risk symptomatic intracranial vertebrobasilar stenoses: long - term outcomes
por: Djurdjevic, Tanja, et al.
Publicado: (2019)

Dual aortic aneurysms with coronary artery and multiple cerebrovascular stenoses
por: Hashimoto, Masafumi, et al.
Publicado: (2021)

Efficacy and Pharmacologic Data of Second-Generation Tyrosine Kinase Inhibitor Nilotinib in BCR-ABL-Positive Leukemia Patients with Central Nervous System Relapse after Allogeneic Stem Cell Transplantation
por: Reinwald, Mark, et al.
Publicado: (2014)

Accuracy of Dose-Saving Artificial-Intelligence-Based 3D Angiography (3DA) for Grading of Intracranial Artery Stenoses: Preliminary Findings
por: Lang, Stefan, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_albm397g9bph3ljk1i01ug4kb5